5
The Ethical Tightrope of Medical AI 12:07 Miles: As much as we love the idea of doctors getting their "pajama time" back, we have to talk about the "Black Box" problem. This is one of the twelve "challenges" identified in the UK’s AI governance strategy. If an AI makes a suggestion—whether it’s a diagnosis or a treatment plan—and it can’t explain *how* it got there, that’s a massive ethical and safety risk.
12:29 Lena: Totally. And it’s not just about the "logic" of the AI. It’s about the "data" it was fed. If the training data is biased—if it’s mostly from one demographic or one type of hospital—the AI might not work as well for everyone else. That "Bias challenge" is a huge part of the regulatory conversation right now.
12:46 Miles: It’s a global "regulatory arms race," really. You’ve got the EU with its AI Act, which basically treats medical AI as "high-risk" by default. That means an extremely high barrier to entry—lots of documentation, transparency requirements, and strict data governance.
13:02 Lena: And then you have the UK, which is taking a more "pro-innovation" approach. Instead of a single new AI law, they’re asking existing regulators—like the MHRA for medical devices—to apply five key principles: safety, transparency, fairness, accountability, and "redress." It’s about embedding AI rules into the systems we already have.
13:21 Miles: It puts a lot of responsibility on the "business user"—the hospital or the tech company. They have to be able to "contest" the AI’s output. If the machine says "this is cancer" and it’s not, who is liable? The UK guidance is trying to figure out where the buck stops. Is it the developer who wrote the code, or the doctor who followed the advice?
13:43 Lena: That "Liability challenge" is a headache. I was reading a paper about "Generative AI in Medical Device Development." It pointed out that even if you’re just using AI to help *design* a new device—like writing the code or organizing the clinical trial data—you’re creating a new set of risks. If the AI "hallucinates" a safety requirement or misses a bug in the code, that could have real-world consequences years down the line.
14:08 Miles: And there’s the "Intellectual Property" angle too. If an LLM was trained on millions of copyrighted medical papers without permission, does that "poison" the output? It’s a legal minefield. But the point is, we can’t wait for the laws to be "perfect" because the tech is moving too fast.
14:26 Lena: Right, the "Access to Data" challenge is real. The most powerful AI models are held by just a few massive organizations. If smaller hospitals or researchers can’t access that level of "compute" power, we might end up with a "digital divide" in healthcare—where only the richest systems have the best AI tools.
14:43 Miles: Which is why some people are pushing for a "self-determined ethical code." Basically, businesses shouldn't wait for the government to tell them what to do. They should build their own frameworks—focusing on things like "traceability," "human-in-the-loop" verification, and protecting "patient-identifiable information."
15:01 Lena: I love the "human-in-the-loop" concept. It’s the idea that AI should be a "clinical decision support" tool, not a "clinical decision maker." In all the trials we’ve discussed—LungIMPACT, the breast MRI studies—the best results always came from the *combination* of the human and the machine.
15:18 Miles: Exactly. The AI is the "augmented intelligence." It does the heavy lifting of data processing, and the human does the "wisdom" part—the context, the empathy, and the final check. But that only works if the human is trained to spot the machine’s mistakes. "AI literacy" is going to be a mandatory skill for every healthcare worker in the next five years.